Mark Kaye
EVP & CFO · Elevance Health, Inc.
IndividualSelling only
- 2024
- Oct 6, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark Kaye files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gail Boudreaux - $1.00M in ELV purchases and sales in the last 12 months
- Charles Morgan Kendrick Jr. - $911K in ELV purchases and sales in the last 12 months
- Steven H. Collis - $870K in ELV purchases and sales in the last 12 months
- Ronald W. Penczek - $766K in ELV purchases and sales in the last 12 months
- Ramiro G. Peru - $366K in ELV purchases and sales in the last 12 months
- Robert L. Dixon Jr. - $61K in ELV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mark Kaye?
Mark Kaye is a corporate insider, tracked as EVP & CFO of Elevance Health, Inc. (ELV). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mark Kaye submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mark Kaye been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.95M) across all tracked filings.
